Kaliumchlorid-Lösung 1 Molar Bernburg

Potassium chloride, the active ingredient in Kaliumchlorid-Lösung 1 Molar Bernburg, is an electrolyte presented as a 1 M solution for injection for intravenous use. It treats hypokalemia and provides potassium replacement therapy in patients requiring electrolyte correction.

GNH USA supplies Kaliumchlorid-Lösung 1 Molar Bernburg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchlorid-Lösung 1 M is used to correct potassium deficits in conditions that affect electrolyte balance.

- Hypokalemia: restores normal serum potassium concentrations. - Cardiac arrhythmia prophylaxis: helps maintain cardiac electrical stability in patients at risk of potassium‑related arrhythmias. - Diuretic‑induced potassium loss: replaces potassium lost during loop or thiazide diuretic therapy.

Adverse reactions may occur with intravenous potassium chloride administration.

Common Side Effects: - Injection site pain - Phlebitis or local irritation - Mild hyperkalemia symptoms (e.g., tingling) - Nausea or vomiting

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrest - Anaphylactic or severe allergic reaction - Life‑threatening arrhythmias - Tissue necrosis if the solution extravasates

Use of Kaliumchlorid-Lösung 1 M requires careful clinical monitoring.

- Monitor serum potassium: check levels before and during therapy. - Adjust dose in renal impairment: reduced clearance may cause accumulation. - Avoid rapid infusion: limit to recommended rate to prevent hyperkalemia. - Caution in patients with cardiac disease: risk of arrhythmias. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may increase serum potassium. - Potassium‑sparing diuretics: additive risk of hyperkalemia. - NSAIDs: can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: hyperkalemia may enhance toxicity. - Beta‑blockers: may mask symptoms of hypokalemia.